ID

20908

Beschreibung

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT00412529

Link

https://clinicaltrials.gov/show/NCT00412529

Stichworte

Versionen (1)
  1. 27.03.17 27.03.17 -
Hochgeladen am

27. März 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Hepatitis B NCT00412529

Englisch

Eligibility Hepatitis B NCT00412529

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
Beschreibung

Age | Chronic Hepatitis B HBeAg positive Compensated

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0524909
UMLS CUI [2,2]
C0392390
UMLS CUI [2,3]
C0205432
able to comply with study regimen and provide written informed consent
Beschreibung

Protocol Compliance | Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0021430
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unwilling to use double barrier method of contraception
Beschreibung

Barrier Contraception Double Unwilling

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004764
UMLS CUI [1,2]
C0205173
UMLS CUI [1,3]
C0558080
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
Beschreibung

HCV coinfection | HDV Coinfection | HIV coinfection

Datentyp

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0011220
UMLS CUI [2,2]
C0275524
UMLS CUI [3]
C4062778
received hepatitis b therapy in the past
Beschreibung

Therapeutic procedure Hepatitis B

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0019163
use of immunomodulatory therapy in past 12 months
Beschreibung

Immunomodulators

Datentyp

boolean

Alias
UMLS CUI [1]
C1527392
history of or symptoms of hepatic decompensation or pancreatitis
Beschreibung

Hepatic decompensation Symptoms | Pancreatitis Symptoms

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1394798
UMLS CUI [1,2]
C1457887
UMLS CUI [2,1]
C0030305
UMLS CUI [2,2]
C1457887
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
Beschreibung

Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0235378
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0332183
UMLS CUI [2,1]
C0235378
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439590
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C1514118
UMLS CUI [3,3]
C0332183
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C1514118
UMLS CUI [4,3]
C0439590
concurrent medication likely to preclude compliance with schedule of evaluations
Beschreibung

Pharmaceutical Preparation Excludes Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
use of other investigational drugs within 30 days of enrollment
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
abnormal laboratory values during screening
Beschreibung

Laboratory test result abnormal

Datentyp

boolean

Alias
UMLS CUI [1]
C0438215
other protocol-defined inclusion/exclusion criteria may apply
Beschreibung

Clinical Trial Eligibility Criteria Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Hepatitis B NCT00412529

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Chronic Hepatitis B HBeAg positive Compensated
Item
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
boolean
C0001779 (UMLS CUI [1])
C0524909 (UMLS CUI [2,1])
C0392390 (UMLS CUI [2,2])
C0205432 (UMLS CUI [2,3])
Protocol Compliance | Informed Consent
Item
able to comply with study regimen and provide written informed consent
boolean
C0525058 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Barrier Contraception Double Unwilling
Item
unwilling to use double barrier method of contraception
boolean
C0004764 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
HCV coinfection | HDV Coinfection | HIV coinfection
Item
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Therapeutic procedure Hepatitis B
Item
received hepatitis b therapy in the past
boolean
C0087111 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
Immunomodulators
Item
use of immunomodulatory therapy in past 12 months
boolean
C1527392 (UMLS CUI [1])
Hepatic decompensation Symptoms | Pancreatitis Symptoms
Item
history of or symptoms of hepatic decompensation or pancreatitis
boolean
C1394798 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0030305 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged
Item
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
boolean
C0235378 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0332183 (UMLS CUI [1,3])
C0235378 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C1514118 (UMLS CUI [3,2])
C0332183 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C1514118 (UMLS CUI [4,2])
C0439590 (UMLS CUI [4,3])
Pharmaceutical Preparation Excludes Protocol Compliance
Item
concurrent medication likely to preclude compliance with schedule of evaluations
boolean
C0013227 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Investigational New Drugs
Item
use of other investigational drugs within 30 days of enrollment
boolean
C0013230 (UMLS CUI [1])
Laboratory test result abnormal
Item
abnormal laboratory values during screening
boolean
C0438215 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video